Logo image
A Novel Cell-Penetrating Peptide Derived from Human Eosinophil Cationic Protein
Journal article   Open access   Peer reviewed

A Novel Cell-Penetrating Peptide Derived from Human Eosinophil Cationic Protein

Shun-lung Fang, Tan-chi Fan, Hua-Wen Fu, Chien-Jung Chen, Chi-Shin Hwang, Ta-Jen Hung, Lih-Yuan Lin and Margaret Dah-Tsyr Chang
PLoS ONE, Vol.8(3), e57318
04/03/2013

Abstract

Cell-penetrating peptides (CPPs) are short peptides which can carry various types of molecules into cells; however, although most CPPs rapidly penetrate cells in vitro, their in vivo tissue-targeting specificities are low. Herein, we describe cell-binding, internalization, and targeting characteristics of a newly identified 10-residue CPP, denoted ECP 32-41 , derived from the core heparin-binding motif of human eosinophil cationic protein (ECP). Besides traditional emphasis on positively charged residues, the presence of cysteine and tryptophan residues was demonstrated to be essential for internalization. ECP 32-41 entered Beas-2B and wild-type CHO-K1 cells, but not CHO cells lacking of cell-surface glycosaminoglycans (GAGs), indicating that binding of ECP 32-41 to cell-surface GAGs was required for internalization. When cells were cultured with GAGs or pre-treated with GAG-digesting enzymes, significant decreases in ECP 32-41 internalization were observed, suggesting that cell-surface GAGs, especially heparan sulfate proteoglycans were necessary for ECP 32-41 attachment and penetration. Furthermore, treatment with pharmacological agents identified two forms of energy-dependent endocytosis, lipid-raft endocytosis and macropinocytosis, as the major ECP 32-41 internalization routes. ECP 32-41 was demonstrated to transport various cargoes including fluorescent chemical, fluorescent protein, and peptidomimetic drug into cultured Beas-2B cells in vitro, and targeted broncho-epithelial and intestinal villi tissues in vivo. Hence this CPP has the potential to serve as a novel vehicle for intracellular delivery of biomolecules or medicines, especially for the treatment of pulmonary or gastrointestinal diseases. © 2013 Fang et al.
url
https://doi.org/10.1371/journal.pone.0057318View
Published (Version of record) Open

Related links

Metrics

1 Record Views

Details

Logo image